A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Description

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Conditions

Growth Hormone Deficiency

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Condition
Growth Hormone Deficiency
Intervention / Treatment

-

Contacts and Locations

Centennial

Ascendis Pharma Investigational Site, Centennial, Colorado, United States, 80112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients who are on treatment with SKYTROFA (lonapegsomatropin)
  • * Patients being clinically managed in USA
  • * Patients with an appropriate written informed consent/assent as applicable for the age of the patient
  • * Patients participating in any interventional clinical study

Ages Eligible for Study

1 Year to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ascendis Pharma Endocrinology Division A/S,

Study Record Dates

2033-03